Sulfonylureas Linked to Higher Risks of Death and Heart Failure (CME/CE)

Sulfonylurea monotherapy for type 2 diabetes was associated with increased risks of all-cause death and congestive heart failure compared with metformin, a large, retrospective study showed.

source : www.medpagetoday.com

Related News:

• More Support for Compression-Only CPR (CME/CE, with video)
• Sleep Disorder May Signal Neuro Conditions to Come (CME/CE, with video)
• Hospital Expansion Not Key to PCI Access in STEMI (CME/CE, with audio)
• Racial Differences in CABG Socioeconomic, Too (CME/CE, with audio)
• Similar Results with Early, Delayed ACL Surgery (CME/CE, with video)
• Model May Aid Decisions After Failed IVF (CME/CE, with audio)
• Happy Hour Comes With Stroke Risk for Fragile Few (CME/CE, with video)
• Glucosamine Fails to Ease Aching Backs (CME/CE, with video)
• For BP More Control Means Less Benefit in T2D (CME/CE, with video)
• ADA: TZD Debate Rages, but What Does It Mean? (CME/CE, with video)

Details :
Submited at Friday, December 4th, 2009 at 1:00 am on Cardiology by ethan
Comment RSS 2.0 - leave a comment - trackback